Lynx1 Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$40.5M	Hold	733,014	–	–	11.7%	4
2025 Q1	$35.4M	Buy	+733,014	New	+$35.4M	12.69%	3